Prospects for fertility control in the European rabbit (Oryctolagus cuniculus) using myxoma virus-vectored immunocontraception
B. H. van Leeuwen A and P. J. Kerr A BA School of Biochemistry and Molecular Biology, Australian National University, Canberra, ACT, Australia.
B Corresponding author. CSIRO Entomology, GPO Box 1700, Canberra, ACT 2601, Australia. Email: peter.kerr@csiro.au
Wildlife Research 34(7) 511-522 https://doi.org/10.1071/WR06167
Submitted: 1 December 2006 Accepted: 26 July 2007 Published: 13 December 2007
Abstract
Research over the last 15 years has examined whether fertility control can reduce overabundant rabbit populations and whether an effective immunocontraceptive agent can be developed and delivered. The results of this research indicate that for fertility control to have an environmental impact at least 80% of females will need to be infertile and that this infertility will need to be permanent. Epidemiological studies suggest that this level of infertility may be very difficult to obtain with a recombinant myxoma virus because of competition with field strains of virus. Research with laboratory rabbits using recombinant myxoma virus to deliver an immunocontraceptive antigen demonstrated that it was possible to obtain the required level of infertility using rabbit zona pellucida C as an antigen. However, only ~50% of animals remained infertile in the medium term. Further research on delivery vector and antigen selection would be needed to produce a practical immunocontraceptive virus for laboratory testing. Such a virus would then need to be optimised for transmissibility before it would be suitable for field testing.
Acknowledgements
We thank our colleagues A. J. Robinson, E. A. McLaughlin, M. K. Holland, H. D. Perkins, A. Wijeratne, B. Inglis, L. E. Perrin and N. French, who contributed to the experimental studies and the unpublished data described in this review.
Anderson, R. M. , and May, R. M. (1982). Coevolution of hosts and parasites. Parasitology 85, 411–426.
| PubMed |
Cameron, C. , Hota-Mitchell, S. , Chen, L. , Barrett, J. , Cao, J.-X. , Macaulay, C. , Willer, D. , Evans, D. , and McFadden, G. (1999). The complete DNA sequence of myxoma virus. Virology 264, 298–318.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
Fenner, F. , and Marshall, I. D. (1957). A comparison of the virulence for European rabbits (Oryctolagus cuniculus) of strains of myxoma virus recovered in the field in Australia, Europe and America. Journal of Hygiene (Cambridge) 55, 149–151.
Fountain, S. , Holland, M. K. , Hinds, L. A. , Janssens, P. A. , and Kerr, P. J. (1997). Interstitial orchitis with impaired steroidogenesis and spermatogenesis in the testes of rabbits infected with an attenuated strain of myxoma virus. Journal of Reproduction and Fertility 110, 161–169.
| PubMed |
Kerr, P. J. , and McFadden, G. (2002). Immune responses to myxoma virus. Viral Immunology 15, 229–246.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
McCabe, V. J. , Tarpey, I. , and Spibey, N. (2002). Vaccination of cats with an attenuated recombinant myxoma virus expressing feline calicivirus capsid protein. Vaccine 20, 2454–2462.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
Mykytowycz, R. (1953). An attenuated strain of the myxomatosis virus recovered from the field. Nature 172, 448–449.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
Russell, R. J. , and Robbins, S. J. (1989). Cloning and molecular characterization of the myxoma virus genome. Virology 170, 147–159.
| Crossref | GoogleScholarGoogle Scholar | PubMed |